We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOI
776
DELISTED
Alliance One International
AOI
$570K 0.01%
+29,825
New +$570K
KBE icon
777
State Street SPDR S&P Bank ETF
KBE
$1.68B
$568K 0.01%
17,010
+50
+0.3% +$1.63K
PRI icon
778
Primerica
PRI
$10B
$568K 0.01%
10,709
+1,775
+20% +$98.1K
FCFS icon
779
FirstCash
FCFS
$9.02B
$565K 0.01%
11,997
+1,938
+19% +$97.4K
SPNC
780
DELISTED
Spectranetics Corp
SPNC
$565K 0.01%
22,500
-1,150
-5% -$26.8K
NTRI
781
DELISTED
NutriSystem, Inc.
NTRI
$564K 0.01%
18,980
+4,250
+29% +$120K
VE
782
DELISTED
VEOLIA ENVIRONNEMENT
VE
$561K 0.01%
24,350
-5,500
-18% -$127K
NOV icon
783
NOV
NOV
$6.95B
$559K ﹤0.01%
15,227
+3,163
+26% +$106K
STT icon
784
State Street
STT
$51.4B
$555K ﹤0.01%
7,974
+130
+2% +$8.5K
BRS
785
DELISTED
Bristow Group, Inc.
BRS
$555K ﹤0.01%
39,607
-15,733
-28% -$188K
HPQ icon
786
HP
HPQ
$26.1B
$554K ﹤0.01%
35,694
-5,508
-13% -$78.5K
PII icon
787
Polaris
PII
$4.16B
$552K ﹤0.01%
+7,128
New +$619K
ONB icon
788
Old National Bancorp
ONB
$10.3B
$549K ﹤0.01%
39,050
+500
+1% +$6.75K
XLB icon
789
State Street Materials Select Sector SPDR ETF
XLB
$8.63B
$547K ﹤0.01%
22,896
-490
-2% -$11.8K
EZU icon
790
iShare MSCI Eurozone ETF
EZU
$9.84B
$545K ﹤0.01%
15,806
+152
+1% +$5.12K
REGN icon
791
Regeneron Pharmaceuticals
REGN
$79.1B
$542K ﹤0.01%
1,349
+179
+15% +$71.8K
AWH
792
DELISTED
Allied World Assurance Co Hld Lt
AWH
$542K ﹤0.01%
13,419
+265
+2% +$10.5K
VAR
793
DELISTED
Varian Medical Systems, Inc.
VAR
$540K ﹤0.01%
6,187
-224
-3% -$18.3K
SPWH icon
794
Sportsman's Warehouse
SPWH
$46M
$539K ﹤0.01%
51,196
+32,251
+170% +$325K
EXPE icon
795
Expedia Group
EXPE
$38.4B
$538K ﹤0.01%
4,613
-824
-15% -$93.2K
HLF icon
796
Herbalife
HLF
$1.31B
$538K ﹤0.01%
+17,362
New +$548K
PTLA
797
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$536K ﹤0.01%
23,621
+9,421
+66% +$221K
BG icon
798
Bunge Global
BG
$20.5B
$533K ﹤0.01%
9,000
-323
-3% -$20.1K
PARA
799
DELISTED
Paramount Global Class B
PARA
$531K ﹤0.01%
18,267
+290
+2% +$15.4K
BECN
800
DELISTED
Beacon Roofing Supply, Inc.
BECN
$530K ﹤0.01%
12,600
+4,343
+53% +$198K

Similar funds

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.